Related Experiment Video
Updated: Jul 19, 2026

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
Published on: December 21, 2019
Intracellular antibody fragment against hepatitis B virus X protein does not inhibit viral replication
Young-Hee Jin1, Seung-Ho Hong, Kyongmin Kim
1Department of Microbiology, Ajou University School of Medicine, San 5 Wonchon-dong Youngtong-gu, Suwon 443-749, Korea.
Abstract:
Replication of the hepatitis B virus is suppressed by deficiency of the X protein. Although several molecules that block cellular targets of X protein reduce the production of hepatitis B virus progeny, the effect of a specific inhibitor of X protein on viral replication has not been investigated. To block X protein specifically, we adopted an intracellular expression approach using H7 single chain variable fragment (H7scFv), an antibody fragment against X protein. We previously demonstrated that cytoplasmic expression of H7scFv inhibits X protein-induced tumorigenicity and transactivation. In this study, intracellular H7scFv expression inhibits reporter gene transactivation but not viral replication determined by endogenous hepatitis B virus polymerase activity assay and real-time PCR. Our findings imply that intracellular expression of antibody fragment against X protein may not be an alternative therapeutic modality for inhibition of hepatitis B virus replication.
Insights
Hepatitis B virus (HBV) X protein deficiency suppresses HBV replication. An intracellular antibody fragment targeting HBV X protein inhibited transactivation but not viral replication, suggesting it’s not a viable therapy for HBV.
Area of Science:
- Hepatology
- Virology
- Molecular Biology
Background:
- Hepatitis B virus (HBV) replication is linked to the X protein.
- Inhibiting cellular targets of HBV X protein reduces viral progeny.
- Specific inhibitors of HBV X protein for viral replication remain uninvestigated.
Purpose of the Study:
- To investigate the effect of a specific inhibitor of HBV X protein on viral replication.
- To assess the efficacy of intracellular H7scFv expression against HBV X protein.
- To determine if targeting HBV X protein is a viable therapeutic strategy.
Main Methods:
- Intracellular expression of H7 single chain variable fragment (H7scFv), an antibody fragment against HBV X protein.
- Assay of reporter gene transactivation.
- Measurement of endogenous HBV polymerase activity.
- Real-time PCR for HBV replication.
Main Results:
- Intracellular H7scFv expression successfully inhibited reporter gene transactivation.
- Intracellular H7scFv expression did not inhibit HBV replication.
- HBV polymerase activity and real-time PCR confirmed lack of inhibition on viral replication.
Conclusions:
- Intracellular expression of an antibody fragment against HBV X protein is ineffective in inhibiting HBV replication.
- Targeting HBV X protein via intracellular antibody fragments may not be a suitable therapeutic approach for HBV infection.
More Related Videos
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Hepatitis
Inhibitors Of Virion Release
Viral Hepatitis I: Introduction
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Leaky Scanning